Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Presicce, Pietro ^a   Orsborn, Kris ^a   King, Eileen ^b   Pratt, Jesse ^b   Fichtenbaum, Carl J ^a   Chougnet, Claire A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIM PROTEIN; CD39 ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CYCLIN B; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GRANZYME A; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR; KI 67 ANTIGEN; LOPINAVIR PLUS RITONAVIR; PERFORIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR FOXP3; APYRASE; BIOLOGICAL MARKER; CD3 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LONGITUDINAL STUDY; MALE; MITOSIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; CYTOLOGY; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; ANTIGENS, CD; ANTIGENS, CD3; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APYRASE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; KI-67 ANTIGEN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 82655183583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028118     Document Type: Article

References (53)

1. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
2. Littman DR, Rudensky AY, (2010) Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
3. Campbell DJ, Koch MA, (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11: 119-130.
4. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, et al. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775.
5. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
6. Ramsdell F, (2003) Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165-168.
7. Kim JM, Rasmussen JP, Rudensky AY, (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
8. Liu J, Gong N, Huang X, Reynolds AD, Mosley RL, et al. (2009) Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol 182: 3855-3865.
9. Moreno Fernandez ME, Rueda C, Rusie L, Chougnet CA, (2011) Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood in press.
10. Boasso A, Vaccari M, Nilsson J, Shearer GM, Andersson J, et al. (2006) Do regulatory T-cells play a role in AIDS pathogenesis? AIDS Rev 8: 141-147.
11. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U, (2008) Natural regulatory T cells and persistent viral infection. J Virol 82: 21-30.
12. Pandrea I, Gaufin T, Brenchley JM, Gautam R, Monjure C, et al. (2008) Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J immunol 181: 6687-6691.
13. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. (2004) HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells. PLoS Biol 2: E198.
14. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, et al. (2005) Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients. J Immunol 174: 3143-3147.
15. Eller MA, Blom KG, Gonzalez VD, Eller LA, Naluyima P, et al. (2011) Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans. PLoS ONE 6: e18779.
16. Sachdeva M, Fischl MA, Pahwa R, Sachdeva N, Pahwa S, (2010) Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. J Acquir Immune Defic Syndr 54: 447-454.
17. Presicce P, Moreno-Fernandez ME, Lages CS, Orsborn KI, Chougnet CA, (2010) Association of two clones allows for optimal detection of human FOXP3. Cytometry A 77: 571-579.
18. Nigam P, Velu V, Kannanganat S, Chennareddi L, Kwa S, et al. (2010) Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J immunol 184: 1690-1701.
19. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, et al. (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. Aids 21: 1525-1534.
20. Lederman MM, (2001) Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 15 (Suppl 2): S11-15.
21. Kurtulus S, Tripathi P, Opferman JT, Hildeman DA, (2010) Contracting the 'mus cells'-does down-sizing suit us for diving into the memory pool? Immunol Rev 236: 54-67.
22. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
23. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, et al. (2007) Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 8: 1246-1254.
24. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, et al. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.
25. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, et al. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
26. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
27. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, et al. (2008) Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 181: 1835-1848.
28. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, et al. (2009) Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 106: 13439-13444.
29. Bi X, Suzuki Y, Gatanaga H, Oka S, (2009) High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 39: 301-309.
30. Lim A, French MA, Price P, (2009) CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy. J Acquir Immune Defic Syndr 51: 248-257.
31. Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, et al. (2008) Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 9: 307-316.
32. Gaardbo JC, Nielsen SD, Vedel SJ, Ersboll AK, Harritshoj L, et al. (2008) Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin Exp Immunol 154: 80-86.
33. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, et al. (2006) HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817.
34. Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, et al. (2010) Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy. PLoS ONE 5: e11659.
35. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 178: 1083-1089.
36. Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, et al. (2006) Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116: 2423-2433.
37. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, et al. (2010) Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
38. Xing S, Fu J, Zhang Z, Gao Y, Jiao Y, et al. (2010) Increased turnover of FoxP3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infection. J Acquir Immune Defic Syndr 54: 455-462.
39. Paiardini M, Cervasi B, Galati D, Dominici S, Albrecht H, et al. (2004) Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS 18: 393-402.
40. Piedimonte G, Corsi D, Paiardini M, Cannavo G, Ientile R, et al. (1999) Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients. AIDS 13: 1159-1164.
41. Zhang SM, Sun Y, Fan R, Xu QZ, Liu XD, et al. (2010) HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation. FASEB J 24: 495-503.
42. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, et al. (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411.
43. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, et al. (2006) Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193: 703-712.
44. Allers K, Loddenkemper C, Hofmann J, Unbehaun A, Kunkel D, et al. (2010) Gut mucosal FOXP3+ regulatory CD4+ T cells and Nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques. J Virol 84: 3259-3269.
45. Moreno-Fernandez ME, Zapata W, Blackard JT, Franchini G, Chougnet CA, (2009) Human Regulatory T Cells Are Targets for Human Immunodeficiency Virus (HIV) Infection, and Their Susceptibility Differs Depending on the HIV Type 1 Strain. J Virol 83: 12925-12933.
46. Sitkovsky M, Lukashev D, Deaglio S, Dwyer K, Robson SC, et al. (2008) Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol 153 (Suppl 1): S457-464.
47. Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, et al. (2010) High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J immunol 185: 134-143.
48. Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, et al. (2010) Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol.
49. Nikolova M, Carriere M, Jenabian MA, Limou S, Younas M, et al. (2011) CD39/Adenosine Pathway Is Involved in AIDS Progression. PLoS Pathog 7: e1002110.
50. Aswad F, Kawamura H, Dennert G, (2005) High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J immunol 175: 3075-3083.
51. Liao H, Hyman MC, Baek AE, Fukase K, Pinsky DJ, (2010) cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem 285: 14791-14805.
52. Becker C, Taube C, Bopp T, Michel K, Kubach J, et al. (2009) Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood 114: 1263-1269.
53. Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, et al. (2010) Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS ONE 5.